8-KRegulation FDExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Regulation FD Disclosure (Feb 7, 2006)

Filed February 7, 2006For Securities:HCA

Summary

This 8-K filing from HCA Healthcare, Inc. (HCA) on February 7, 2006, primarily announces a pricing agreement with Zimmer. While the specifics of the agreement are not detailed within the 8-K itself, it is presented as a material event via a press release filed as an exhibit. Investors should note that this filing serves as a disclosure mechanism for material information under Regulation FD, ensuring broad and simultaneous dissemination of information to the public.

Key Highlights

  • 1HCA Healthcare, Inc. announced a pricing agreement with Zimmer.
  • 2The agreement details are provided in a press release filed as Exhibit 99.1.
  • 3The filing was made on February 7, 2006, under Item 7.01 (Regulation FD Disclosure).
  • 4This filing ensures that the information about the Zimmer agreement is publicly disclosed.
  • 5The Chief Financial Officer, R. Milton Johnson, signed the filing.
  • 6The press release itself is the primary source of detailed information regarding the Zimmer agreement.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose a pricing agreement between HCA Healthcare, Inc. and Zimmer, as required by Regulation FD. The details of this agreement are contained in an attached press release.

Zimmer is a manufacturer of orthopedic reconstructive products, trauma products, spine, dental and related surgical products. A pricing agreement typically indicates a significant commercial relationship, potentially impacting HCA's cost of goods sold for medical supplies and, consequently, its profitability. Investors would look to the accompanying press release for the financial implications.

More details about the pricing agreement can be found in the press release dated February 7, 2006, which is filed as Exhibit 99.1 to this 8-K report. Investors should refer to that document for specific terms and potential impacts.

No, this specific 8-K filing does not include financial statements or updated financial guidance. Its primary function is to announce the pricing agreement with Zimmer through a press release under Regulation FD.